XtalPi
Lei Fang is a highly experienced individual with a background in computational chemistry, specializing in computer-aided drug design for diabetes, cancer, and addiction related targets. Lei has held various positions, including Senior Director, Director, and Senior Scientist, at companies like XtalPi Inc., as well as research roles at Florida Atlantic University, University of Maryland, and University of Kentucky. Lei holds a Ph.D. in Pharmaceutical Sciences from the University of Kentucky, a Master's Degree in Computational Chemistry from the University of Chinese Academy of Sciences, and a Bachelor's degree in Polymer Science and Engineering from Sichuan University.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.